TE_19749
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding |
| Tumor-specific score | 261.49 |
| Counts of samples | TCGA_tumor:231; TCGA_normal:0; GTEx:0 |
| TSS | chr9(-):74424658 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_19749.21 | - | Intergenic | Non-coding | Non-coding | chr9(-):74359364,74359384,74359645,74359741,74375403,74375560,74424532,74424659 |
| teRNA_19749.22 | - | Intergenic | Non-coding | Non-coding | chr9(-):74345675,74345695,74375403,74375560,74424532,74424659 |
| teRNA_19749.23 | - | Intergenic | Non-coding | Non-coding | chr9(-):74345675,74345695,74359645,74359741,74375403,74375560,74424532,74424659 |
| teRNA_19749.24 | - | Intergenic | Non-coding | Non-coding | chr9(-):74359721,74359741,74375403,74375560,74424532,74424659 |
| teRNA_19749.25 | - | Intergenic | Non-coding | Non-coding | chr9(-):74295576,74295596,74343562,74343684,74345527,74345695,74375403,74375560,74424532,74424659 |
| teRNA_19749.26 | - | Intergenic | Non-coding | Non-coding | chr9(-):74288764,74288784,74375403,74375560,74424532,74424659 |
| teRNA_19749.27 | - | Intergenic | Non-coding | Non-coding | chr9(-):74303214,74303234,74315801,74316036,74343562,74343684,74345527,74345695,74375403,74375560,74424532,74424659 |
| teRNA_19749.28 | - | Intergenic | Non-coding | Non-coding | chr9(-):74345675,74345695,74375403,74375560,74423894,74424156,74424532,74424659 |
| teRNA_19749.29 | - | Intergenic | Non-coding | Non-coding | chr9(-):74375540,74375560,74397489,74397550,74424532,74424659 |
| teRNA_19749.30 | - | Intergenic | Non-coding | Non-coding | chr9(-):74345675,74345695,74423894,74424659 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
